Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients

Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients

Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patient...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alina Babenko, Elena Ivanovna Krasilnikova, Nikolay Pavlovich Likhonosov, Anna Pavlovna Likhonosova, Elena Nikolaevna Grineva
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2014-12-01
Series:	Сахарный диабет
Subjects:	continuous glucose monitoring glycaemic variability incretins glp-1 analogues/mimetics dpp-4 inhibitors
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6406
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
by: Yury Ivanovich Suntsov
Published: (2012-03-01)

Chapter 11: The approach to achieving glycaemic control
by: The Society for Endocrinology Metabolism and Diabetes of South Africa
Published: (2018-06-01)

Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
by: Gail Mkele
Published: (2013-12-01)

New indications for exenatide therapy of type 2 diabetes mellitus
by: Olga Konstantinovna Vikulova, et al.
Published: (2010-09-01)

CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01)

Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus
by: T. V. Saprina, et al.
Published: (2011-12-01)

Association between Physical Activity Energy Expenditure and Continuous Glucose Monitor-Derived Metrics: Data from the ZOE PREDICT 1 Study
by: Harry A. Smith, et al.
Published: (2023-12-01)

Editorial: Incretin-based therapies in the treatment of metabolic syndrome: expanding roles beyond weight management
by: Kexin Zhang, et al.
Published: (2025-08-01)

Effect of GIP and GLP-1 infusion on bone resorption in glucose intolerant, pancreatic insufficient cystic fibrosis
by: Wang Shin Lei, et al.
Published: (2025-06-01)

Effect of high intakes of protein-only and carbohydrate-only on plasma metabolites and hormones, in addition to nitrogen excretion
by: Matthieu Clauss, et al.
Published: (2025-08-01)

Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients
by: Umael Khan, et al.
Published: (2025-08-01)

Perspectives of impaired glucose tolerance management in patients with metabolic syndrome
by: K. P. Ivanov, et al.
Published: (2011-08-01)

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes
by: Alena V. Tiselko, et al.
Published: (2019-12-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
by: D. V. Kurkin, et al.
Published: (2024-01-01)

Diurnal Differences in Glycaemic Responses to Meals Containing Different Bread Types among Persons at Risk for Type 2 Diabetes—Preliminary Results from a CarbHealth Sub-Study
by: Alena M. Schadow, et al.
Published: (2024-02-01)

Comparative effectiveness of different exercise modality on glycaemic control and lipid profile for prediabetes: systematic review and network meta-analysis
by: Ruixiang Yan, et al.
Published: (2025-07-01)

Liraglutide for the treatment of obesity
by: Elmien Bronkhorst, et al.
Published: (2016-05-01)

Features of the functional state of the enteropancreatic hormonal system in pregnant women with gestational diabetes mellitus
by: F. O. Ushanova, et al.
Published: (2023-12-01)

Correlation Between Glycaemic Control and Body Mass Index in Nigerian Type I1 Diabetic Patients Attending Medical Outpatient Clinics UITH Ilorin.
by: AbdulAzeez, I.M., Okesina, A.B., Akande, A.A., Adebisi, S.A., Biliaminu, S.A., Oladosu, W.O. and AbdulAzeez, I.F.
Published: (2017-06-01)

Glycaemic control in labour with diabetes: GILD, a scoping study
by: Nia Wyn Jones, et al.
Published: (2025-08-01)

The influence of family characteristics on glycaemic control among adult patients with type 2 diabetes mellitus attending the general outpatient clinic, National Hospital, Abuja, Nigeria
by: Bethrand B. Odume, et al.
Published: (2015-11-01)

The validity of monitoring the control of diabetes with random blood glucose testing
by: O.F. Daramola, et al.
Published: (2013-12-01)

Relationship between glycaemic control with microalbuminuria and trace metals in patients with type 2 diabetes mellitus: A cross-sectional study from University of Ilorin teaching hospital, Nigeria
by: Abdul Azeez IM, et al.
Published: (2025-01-01)

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes
by: James Goodman, et al.
Published: (2025-07-01)

Prognostic effects of glycaemic variability on diastolic heart failure and type 2 diabetes mellitus: insights and 1-year mortality machine learning prediction model
by: Zhenkun Yang, et al.
Published: (2024-11-01)

Impact of a novel smartphone application for remote monitoring of gestational diabetes on glycaemic control and birth outcomes: a pilot observational study
by: S Smyth, et al.
Published: (2025-07-01)

Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight
by: Claire H. Feetham, et al.
Published: (2025-09-01)

Effectiveness prediction of Evogliptin treatment in type 2 diabetes mellitus in russian-korean population
by: Anna A. Mosikian, et al.
Published: (2018-11-01)

The Influence of Yoga on HbA1c Levels in Patients with Type 2 Diabetes Mellitus: A Systematic Review
by: Sumedha, et al.
Published: (2025-05-01)

STUDI IN SILICO POTENSI SENYAWA ALLIIN BAWANG PUTIH (Allium sativum) SEBAGAI INHIBITOR DPP-4 PADA DIABETES MELLITUS
by: Martina Kurnia Rohmah
Published: (2018-03-01)

Effect of self-monitoring of blood glucose on glycaemic outcome among type 2 diabetic patients
by: Oluwajimi Olanrewaju Sodipo, et al.
Published: (2017-12-01)

Mimetic set and match: Around Shaffer’s “Sleuth”
by: Andrzej Fretschel-Hojarski
Published: (2025-04-01)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

Genetic mechanisms of disorders in the metabolism of polyunsaturated fatty acids in the development of chronic inflammation in bronchial asthma
by: O. Yu. Kytikova, et al.
Published: (2025-07-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

The commercial availability of plant-based phytochemical components used in GLP-1 inhibition for the treatment of type-2 diabetes
by: Sharanjeet Kour, et al.
Published: (2025-08-01)

Training-specific effects on metabolic-inflammatory mediators: GLP-1 and Dectin-1 changes following resistance, continuous, or interval exercise in overweight women
by: Leila Nouri Ain, et al.
Published: (2025-03-01)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018-06-01)